News
Keep up to date with our latest news
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry Move combines Envision’s global leadership position in medical affairs communications with Vitaccess’ award-winning capabilities in...
Keeping it real #5 – Importance of caregiver perspective in real-world evidence
Missed our webinar about the importance of caregiver perspective in real-world studies? Watch it here! On March 2, we hosted the 5th webinar in the Vitaccess “Keeping it real” series. Dr Catherine Bottomley, Director of Patient-Centered Outcomes, and Dr Mark Larkin,...
Keeping it real #4 – Safety reporting in pre- to post-approval RWE studies
Missed our webinar about adding safety reporting to create continuous pre- to post-approval longitudinal digital real-world evidence studies? Watch it here! On 26th January 2022, Vitaccess hosted the fourth webinar in the “Keeping it real” series. Dr Mark...
Keeping it real #3 – Co-creating rare disease registries
Missed our webinar about co-creating rare disease registries? Watch it here! On Monday 15th November, Vitaccess hosted the 3rd webinar in the “Keeping it real” series. Dr Mark Larkin, CEO and Founder of Vitaccess; Dr Catherine Bottomley, Director of...
Vitaccess at Virtual ISPOR Europe 2021
ISPOR Europe 2021 is just around the corner and the Vitaccess team is looking forward to sharing insights with you during the event as well as our poster presentations. We will be part of the podium session “Two years of COVID-19: what has been the global impact on...
Early access innovator, RareiTi, and innovative research organization, Vitaccess, partner on real-world data services in rare disease
RareiTi Inc., a data-driven early access and clinical patient services company, and Vitaccess Ltd, a multi-award-winning digital real-world evidence (RWE) research and strategy specialist, announce a collaboration offering unique services in RWE to support...
Vitaccess receives ISO 9001 and ISO 27001 certifications
In record time, Vitaccess has successfully achieved UKAS-accredited certification, through Approachable Certification (our audit body), to two ISO standards. With a process that started only 6 months earlier, the Vitaccess team came together to achieve this huge...
Keeping it real #2 – Digital endpoints and HEOR – moving towards a richer understanding of disease impact and therapeutic benefit.
On Thursday 29th July 2021, Vitaccess hosted the second webinar in the “Keeping it real” series.Dr Mark Larkin, Founder and CEO of Vitaccess, and Giles Monnickendam, Director of HEOR, discussed the emerging role of digital endpoints and measures in health economics...
Keeping it real #1 – real-world evidence in rare disease
Missed our webinar about real-world evidence in rare disease? Watch it here! On the 10th June 2021, Vitaccess hosted the first webinar of its brand new series named “Keeping it real”. For this first edition, Vitaccess’ Founder and CEO Dr Mark Larkin and Senior...
